Lisata Therapeutics, Inc.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: US1280583022

USD

3.47

0.00 (0.00%)

Jun 23

NAS

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Oncternal Therapeutics, Inc.

Acorda Therapeutics, Inc.

Cosmos Health, Inc.

Galecto, Inc.

Protara Therapeutics, Inc.

Lisata Therapeutics, Inc.

Acurx Pharmaceuticals, Inc.

Azitra, Inc.

Hepion Pharmaceuticals, Inc.

TFF Pharmaceuticals, Inc.

Acer Therapeutics, Inc.

Why is Lisata Therapeutics, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Lisata Therapeutics, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Lisata Therapeutics, Inc.

45.19%

0.01

111.32%

S&P 500

22.24%

1.67

13.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.19%

EBIT Growth (5y)

1.86%

EBIT to Interest (avg)

-24.48

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.02

Sales to Capital Employed (avg)

0.04

Tax Ratio

4.75%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

12.93%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.06

EV to EBIT

-1.62

EV to EBITDA

-1.63

EV to Capital Employed

-26.74

EV to Sales

29.44

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-111.65%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -13.63 MM

NET PROFIT(HY)

Higher at USD -7.44 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -119.53 %

-11What is not working for the Company

NET SALES(HY)

At USD 0.1 MM has Grown at -90%

ROCE(HY)

Lowest at -90.13%

CASH AND EQV(HY)

Lowest at USD 29.02 MM

Here's what is working for Lisata Therapeutics, Inc.

Operating Cash Flow

Highest at USD -13.63 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit

Higher at USD -7.44 MM

than preceding 12 month period ended Mar 2026

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Debt-Equity Ratio

Lowest at -119.53 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Lisata Therapeutics, Inc.

Net Sales

At USD 0.1 MM has Grown at -90%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (USD MM)

Cash and Eqv

Lowest at USD 29.02 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents